Peptide research literature is full of specialized vocabulary, and a shared glossary helps laboratory personnel read product documentation and published studies accurately. All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. This page defines common terms in plain English so researchers can interpret a certificate of analysis or a methods section with confidence.
Physical form and preparation terms
Lyophilized describes a compound that has been freeze-dried: water is removed under vacuum from a frozen sample, leaving a dry powder or cake that is more stable in storage. Reconstitution is the laboratory step of returning a lyophilized powder to a liquid state by adding a defined solvent, typically bacteriostatic or sterile water, so the material can be handled volumetrically in benchtop work. Researchers exploring these handling procedures often consult our overview of how to reconstitute peptides for general technique context. This glossary describes terminology only and does not provide preparation protocols for any use in humans or animals.
Pharmacology and mechanism terms
An agonist is a molecule that binds a receptor and activates the downstream signaling associated with that receptor, in contrast to an antagonist, which binds without activating. An incretin is a class of gut-derived signaling peptides studied for their role in glucose and metabolic regulation; in published research, incretin pathways such as GLP-1 and GIP signaling are examined in cell and animal models. Receptor refers to the protein target a peptide binds, and selectivity describes how preferentially a molecule acts on one receptor over others. These are descriptive scientific terms; researchers study these mechanisms, and BioRegen makes no claim that any compound produces a therapeutic outcome.
Pharmacokinetic terms
Half-life is the time required for the concentration of a compound in a defined system to fall to half its initial value; in pharmacology research it informs how investigators design sampling timepoints in a study. Bioavailability describes the fraction of an administered amount that reaches the systemic compartment in a model system, and clearance describes the rate at which it is removed. These parameters are reported in the experimental literature as measured properties of a model, not as guidance for any human or veterinary application.
Quality, purity, and documentation terms
Purity (HPLC) refers to the percentage of the intended compound in a sample as measured by high-performance liquid chromatography, an analytical method that separates components so impurities can be quantified. Mass spectrometry (MS) confirms molecular identity and mass. A Certificate of Analysis (CoA) is the document a manufacturer provides summarizing test results such as HPLC purity, identity, and appearance for a specific lot. Comparing CoA values across compounds and lots is a routine part of evaluating reference materials in a research setting. To compare items by these specifications, researchers can use our research finder or browse the full catalog in our research compound shop.
Frequently asked questions
What does HPLC purity actually measure?
HPLC purity is the proportion of the target compound relative to detectable impurities, expressed as a percentage from a chromatographic separation. It is an analytical specification reported on a Certificate of Analysis and is used by researchers to characterize reference material; it is not a statement about any use of the compound.
Is "lyophilized" the same as a solution?
No. A lyophilized compound is a freeze-dried solid. It becomes a solution only after reconstitution with an appropriate solvent. The two terms describe different physical states encountered when handling research materials in a laboratory.
Why do researchers track half-life?
Half-life is a measured pharmacokinetic property that helps investigators design experiments, such as choosing sampling timepoints in a model system. It is reported in published studies as a characteristic of the compound under specific experimental conditions.
New to evaluating research compounds? Start with our research guide for background on documentation and terminology, and use code RESEARCH10 for 10% off your first order. When you are ready to compare specifications side by side, browse the catalog in our research compound shop.
Selected research references
- Liu QK. Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists. Front Endocrinol. 2024. https://doi.org/10.3389/fendo.2024.1431292
- Coskun T, et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist: from discovery to clinical proof of concept. Mol Metab. 2018. https://doi.org/10.1016/j.molmet.2018.09.009
Reference metadata sourced via PubMed.
This glossary is provided strictly for laboratory and educational research purposes. No compound referenced is approved for human or veterinary use, none of this content is medical advice, and nothing here should be interpreted as a claim that any compound treats, cures, or prevents any condition. BioRegen does not make or endorse such claims.
